The global amyotrophic lateral sclerosis industry is on the brink of substantial expansion, with forecasts revealing a promising compound annual growth rate (CAGR) of 6% between 2023 and 2033. A recent in-depth study anticipates a noteworthy surge in market size, projecting an increase from the expected US$ 743.90 million in 2023 to an impressive US$ …